CYP3A7 Gene - The Culprit Behind Poor Outcomes Of Cancer Treatment

Cancer research has come a long way. In recent years, there has been a growing emphasis on research into the genetic association with treatment efficacy. Amid this backdrop, a new study has found that it is because of the gene called CYP3A7 that some patients with breast cancer, lung cancer and leukemia fare poorly after treatment.

from RTT - Biotech http://ift.tt/1LfU5Sk
via IFTTT